End-organ consequences of the Fontan operation: liver fibrosis, protein-losing enteropathy and plastic bronchitis.. Protein-losing enteropathy in patients with congenital heart disease..
Trang 1circulation causes early, severe liver damage
Should we offer patients a tailored strategy? Int
J Cardiol 2016;209:60–65.
183 Heyne K, Shin YS, Schwinger E Double
heterozygosity (transferase-/epimerase-defect)
and galactosemia cataract Monatsschr
Kinderheilkd 1988;136(12):828–830.
184 Wernovsky G, Lihn SL, Olen MM Creating a
lesion-specific “roadmap” for ambulatory care following surgery for complex congenital
cardiac disease Cardiol Young 2017;27(4):648–
662
185 Gewillig M, Goldberg DJ Failure of the fontan
circulation Heart Fail Clin.2014;10(1):105–
116
186 Rychik J, Goldberg D, Rand E, et al End-organ
consequences of the Fontan operation: liver
fibrosis, protein-losing enteropathy and plastic
bronchitis Cardiol Young 2013;23(6):831–840.
187 Dori Y Novel lymphatic imaging techniques
Tech Vasc Interv Radiol 2016;19(4):255–261.
188 Itkin M, Piccoli DA, Nadolski G, et al Protein-losing enteropathy in patients with congenital
heart disease J Am Coll Cardiol.
2017;69(24):2929–2937
189 Itkin MG, McCormack FX, Dori Y Diagnosis
Trang 2and treatment of lymphatic plastic bronchitis in adults using advanced lymphatic imaging and
percutaneous embolization Ann Am Thorac Soc.
2016;13(10):1689–1696
190 Ludwig J, Linhart P, Baggenstoss AH Hepatic
lymph drainage in cirrhosis and congestive heart failure A postmortem lymphangiographic study
Arch Pathol 1968;86(5):551–562.
191 Avitabile CM, Goldberg DJ, Dodds K, et al A
multifaceted approach to the management of plastic bronchitis after cavopulmonary
palliation Ann Thorac Surg 2014;98(2):634–
640
192 Racz J, Mane G, Ford M, et al
Immunophenotyping and protein profiling of Fontan-associated plastic bronchitis airway
casts Ann Am Thorac Soc.2013;10(2):98–107.
193 Schumacher KR, Stringer KA, Donohue JE, et
al Fontan-associated protein-losing enteropathy
and plastic bronchitis J Pediatr.
2015;166(4):970–977
194 Dori Y, Itkin M Etiology and new treatment
options for patients with plastic bronchitis J
Thorac Cardiovasc Surg 2016;152(2):e49–e50.
195 Brooks K, Caruthers RL, Schumacher KR,
Stringer KA Pharmacotherapy challenges of Fontan-associated plastic bronchitis: a rare
Trang 32013;33(9):922–934
196 Lubcke NL, Nussbaum VM, Schroth M Use of
aerosolized tissue plasminogen activator in the
treatment of plastic bronchitis Ann
Pharmacother 2013;47(3):e13.
197 Dori Y, Keller MS, Rome JJ, et al Percutaneous
lymphatic embolization of abnormal pulmonary lymphatic flow as treatment of plastic bronchitis
in patients with congenital heart disease
Circulation 2016;133(12):1160–1170.
198 Rychik J Protein-losing enteropathy after Fontan
operation Congenit Heart Dis 2007;2:288–300.
199 John AS, Johnson JA, Khan M, et al Clinical
outcomes and improved survival in patients with protein-losing enteropathy after the Fontan
operation J Am Coll Cardiol 2014;64(1):54–62.
200 Mertens L, Hagler D, Sauer U, Somerville J,
Gewillig M Protein-losing enteropathy after the Fontan operation: an international multicenter
study PLE study group J Thorac Cardiovasc Surg 1998;115(5):1063–1073.
201 Goldberg DJ, Dodds K, Avitabile CM, et al
Children with protein-losing enteropathy after the Fontan operation are at risk for abnormal
bone mineral density Pediatr Cardiol.
2012;33(8):1264–1268